Skip to main content
CDC Website

Diagnostic Tests

3 Facts You Should Know About Hepatitis C

This poster states three important facts people should know about hepatitis C: it's a leading cause of liver cancer, millions of Americans have it, but don't know it, and treatments can eliminate the virus. The poster advises individuals to talk to their doctor about getting tested. The poster is also available in a smaller size, 26" x 36", at http://www.cdc.gov/knowmorehepatitis/media/pdfs/poster-facts24x36.pdf.

3 Facts You Should Know About Hepatitis C

This poster states three important facts people should know about hepatitis C: it's a leading cause of liver cancer, millions of Americans have it, but don't know it, and treatments can eliminate the virus. The poster advises individuals to talk to their doctor about getting tested. The poster is also available in a smaller size, 8.5" x 11", at http://www.cdc.gov/knowmorehepatitis/Media/PDFs/Poster-Facts.pdf.

Evaluating Liver Test Abnormalities: Understanding the Pathophysiology of Liver Disease

This online course teaches the user how to evaluate abnormal liver chemistries in the context of a broad understanding of the pathophysiology of liver injury. It is designed for providers who are non-liver specialists, particularly mid-level healthcare providers. Participants will learn common differential diagnosis for each pattern of liver injury, to initiate appropriate investigations based on the pattern of liver injury, recognize clinical manifestations of hepatic failure, and identify patients with liver disease who require hospitalization.

Know Hepatitis B Campaign

This information sheet discusses the Know Hepatitis B Campaign, the first national multilingual communications campaign to increase hepatitis B testing among Asian Americans and Pacific Islanders. The campaign focuses Asian Americans and Pacific Islanders as they are one of the groups in the United States most affected by hepatitis B, which can cause potentially fatal liver damage and liver cancer. CDC conducted the campaign in partnership with Hep B United, a nationwide coalition of community organizations working to increase hepatitis B awareness and testing.

Hepatitis C Virus (HCV) Infection Testing for Diagnosis

This information sheet is a chart on hepatitis C virus diagnostic testing. It explains the procedures followed when an individual is tested for hepatitis C virus infection. If the test is nonreactive, then no antibody was detected and no further action is necessary. If the test is reactive, it is followed by a serological tests: testing for HCV ribonucleic acid (RNA) or follow-up testing for HCV antibody. If no RNA is detected, then the individual in not infected, if he/she tests positive for HCV RNA, then he/she has HCV infection and is referred for care.

Hepatitis C: Por qué los Baby Boomers Deben Hacerse un Análisis de Hepatitis C?

This information sheet discusses why baby boomers should get tested for Hepatitis C. It states that baby boomers are five times more likely to have Hepatitis C due to contaminated blood and blood products before widepread screening of blood in 1992 and other precautions were adopted or from injecting drugs. The information sheet discusses the symptoms, long term effects, and treatment of hepatitis C.

Hepatitis C: Why Baby Boomers Should Get Tested

This information sheet discusses why baby boomers should get tested for Hepatitis C. It states that baby boomers are five times more likely to have Hepatitis C due to contaminated blood and blood products before widepread screening of blood in 1992 and other precautions were adopted or from injecting drugs. The information sheet discusses the symptoms, long term effects, and treatment of hepatitis C.

Hepatitis C: Testing Baby Boomers Saves Lives

This information sheet discusses what Hepatitis C is and why baby boomers should get tested for Hepatitis C. It states that an estimated three million adults in the US have Hepatitis C and that baby boomers are five times more likely to have Hepatitis C due to contaminated blood and blood products before widepread screening of blood in 1992 and other precautions were adopted or from injecting drugs.